{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:02:29Z","timestamp":1787792549977,"version":"build-2784847793"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,27]]},"DOI":"10.7759\/cureus.39573","type":"journal-article","created":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T19:00:42Z","timestamp":1685214042000},"source":"Crossref","is-referenced-by-count":3,"title":["Successful Treatment of Tourette Syndrome With a Combination of Guanfacine and Aripiprazole: A Case Series"],"prefix":"10.7759","author":[{"given":"Tikku","family":"George","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallory","family":"Emig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratap","family":"Chand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heer","family":"Hendry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.12703\/r\/10-70","article-title":"Recent progress on Tourette syndrome","volume":"10","author":"Ueda K","year":"2021","unstructured":"Ueda K, Black KJ. Recent progress on Tourette syndrome. Fac Rev. 2021, 10:70. 10.12703\/r\/10-70","journal-title":"Fac Rev"},{"key":"ref2","article-title":"Tourette syndrome in a longitudinal perspective. Clinical course of tics and comorbidities, coexisting psychopathologies, phenotypes and predictors","volume":"65","author":"Groth C","year":"2018","unstructured":"Groth C. Tourette syndrome in a longitudinal perspective. Clinical course of tics and comorbidities, coexisting psychopathologies, phenotypes and predictors. Dan Med J. 2018, 65:","journal-title":"Dan Med J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-015-0430-0","article-title":"Perceptions of treatment for tics among young people with Tourette syndrome and their parents: a mixed methods study","volume":"15","author":"Cuenca J","year":"2015","unstructured":"Cuenca J, Glazebrook C, Kendall T, et al.. Perceptions of treatment for tics among young people with Tourette syndrome and their parents: a mixed methods study. BMC Psychiatry. 2015, 15:46. 10.1186\/s12888-015-0430-0","journal-title":"BMC Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s40474-019-00168-8","article-title":"Assessment and management of tic disorders in pediatric primary care settings","volume":"6","author":"Yadegar M","year":"2019","unstructured":"Yadegar M, Guo S, Ricketts EJ, Zinner SH. Assessment and management of tic disorders in pediatric primary care settings. Curr Dev Disord Rep. 2019, 6:159-72. 10.1007\/s40474-019-00168-8","journal-title":"Curr Dev Disord Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000055434.39968.67","article-title":"A placebo-controlled trial of risperidone in Tourette syndrome","volume":"60","author":"Scahill L","year":"2003","unstructured":"Scahill L, Leckman JF, Schultz RT, Katsovich L, Peterson BS. A placebo-controlled trial of risperidone in Tourette syndrome. Neurology. 2003, 60:1130-5. 10.1212\/01.wnl.0000055434.39968.67","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X16666180828095131","article-title":"Psychopharmacotherapy of obsessive-compulsive symptoms within the framework of Tourette syndrome","volume":"17","author":"Rothenberger A","year":"2019","unstructured":"Rothenberger A, Roessner V. Psychopharmacotherapy of obsessive-compulsive symptoms within the framework of Tourette syndrome. Curr Neuropharmacol. 2019, 17:703-9. 10.2174\/1570159X16666180828095131","journal-title":"Curr Neuropharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2012.10.004","article-title":"Neuromodulation in Tourette syndrome: dopamine and beyond","volume":"37","author":"Buse J","year":"2013","unstructured":"Buse J, Schoenefeld K, M\u00fcnchau A, Roessner V. Neuromodulation in Tourette syndrome: dopamine and beyond. Neurosci Biobehav Rev. 2013, 37:1069-84. 10.1016\/j.neubiorev.2012.10.004","journal-title":"Neurosci Biobehav Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007467","article-title":"Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders","volume":"92","author":"Pringsheim T","year":"2019","unstructured":"Pringsheim T, Holler-Managan Y, Okun MS, et al.. Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019, 92:907-15. 10.1212\/WNL.0000000000007467","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.7b00460","article-title":"Update on the pharmacological treatment of tics with dopamine-modulating agents","volume":"9","author":"Mogwitz S","year":"2018","unstructured":"Mogwitz S, Buse J, Wolff N, Roessner V. Update on the pharmacological treatment of tics with dopamine-modulating agents. ACS Chem Neurosci. 2018, 9:651-72. 10.1021\/acschemneuro.7b00460","journal-title":"ACS Chem Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2013.04.003","article-title":"Antipsychotic augmentation of selective serotonin reuptake inhibitors in resistant tic-related obsessive-compulsive disorder in children and adolescents: a naturalistic comparative study","volume":"47","author":"Masi G","year":"2013","unstructured":"Masi G, Pfanner C, Brovedani P. Antipsychotic augmentation of selective serotonin reuptake inhibitors in resistant tic-related obsessive-compulsive disorder in children and adolescents: a naturalistic comparative study. J Psychiatr Res. 2013, 47:1007-12. 10.1016\/j.jpsychires.2013.04.003","journal-title":"J Psychiatr Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1017\/9781108186599","article-title":"Pharmacological Treatment of Tics","author":"Cavanna AE","year":"2020","unstructured":"Cavanna AE. Pharmacological Treatment of Tics. Cambridge University Press, Cambridge; 2020. 10.1017\/9781108186599"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211032445","article-title":"Pharmacological treatment for Tourette syndrome in children and adults: What is the quality of the evidence? A systematic review","volume":"35","author":"Besag FM","year":"2021","unstructured":"Besag FM, Vasey MJ, Lao KS, Chowdhury U, Stern JS. Pharmacological treatment for Tourette syndrome in children and adults: What is the quality of the evidence? A systematic review. J Psychopharmacol. 2021, 35:1037-61. 10.1177\/02698811211032445","journal-title":"J Psychopharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-124872","article-title":"Comparative efficacy and safety of antipsychotic drugs for tic disorders: a systematic review and Bayesian network meta-analysis","volume":"52","author":"Yang C","year":"2019","unstructured":"Yang C, Hao Z, Zhang LL, Zhu CR, Zhu P, Guo Q. Comparative efficacy and safety of antipsychotic drugs for tic disorders: a systematic review and Bayesian network meta-analysis. Pharmacopsychiatry. 2019, 52:7-15. 10.1055\/s-0043-124872","journal-title":"Pharmacopsychiatry"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00416","article-title":"Aripiprazole improves associated comorbid conditions in addition to tics in adult patients with Gilles de la Tourette syndrome","volume":"10","author":"Gerasch S","year":"2016","unstructured":"Gerasch S, Kanaan AS, Jakubovski E, M\u00fcller-Vahl KR. Aripiprazole improves associated comorbid conditions in addition to tics in adult patients with Gilles de la Tourette syndrome. Front Neurosci. 2016, 10:416. 10.3389\/fnins.2016.00416","journal-title":"Front Neurosci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2147\/PHMT.S87121","article-title":"Safety and efficacy of aripiprazole for the treatment of pediatric Tourette syndrome and other chronic tic disorders","volume":"7","author":"Cox JH","year":"2016","unstructured":"Cox JH, Seri S, Cavanna AE. Safety and efficacy of aripiprazole for the treatment of pediatric Tourette syndrome and other chronic tic disorders. Pediatric Health Med Ther. 2016, 7:57-64. 10.2147\/PHMT.S87121","journal-title":"Pediatric Health Med Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2021.1893693","article-title":"Aripiprazole for the treatment of Tourette syndrome","volume":"21","author":"Cox JH","year":"2021","unstructured":"Cox JH, Cavanna AE. Aripiprazole for the treatment of Tourette syndrome. Expert Rev Neurother. 2021, 21:381-91. 10.1080\/14737175.2021.1893693","journal-title":"Expert Rev Neurother"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20765","article-title":"Safety of 80 antidepressants, antipsychotics, anti-attention-deficit\/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects","volume":"19","author":"Solmi M","year":"2020","unstructured":"Solmi M, Fornaro M, Ostinelli EG, et al.. Safety of 80 antidepressants, antipsychotics, anti-attention-deficit\/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects. World Psychiatry. 2020, 19:214-32. 10.1002\/wps.20765","journal-title":"World Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2020.1820985","article-title":"Safety and tolerability of antipsychotic agents in neurodevelopmental disorders: a systematic review","volume":"19","author":"Iasevoli F","year":"2020","unstructured":"Iasevoli F, Barone A, Buonaguro EF, Vellucci L, de Bartolomeis A. Safety and tolerability of antipsychotic agents in neurodevelopmental disorders: a systematic review. Expert Opin Drug Saf. 2020, 19:1419-44. 10.1080\/14740338.2020.1820985","journal-title":"Expert Opin Drug Saf"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-011-0163-7","article-title":"European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment","volume":"20","author":"Roessner V","year":"2011","unstructured":"Roessner V, Plessen KJ, Rothenberger A, et al.. European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. Eur Child Adolesc Psychiatry. 2011, 20:173-96. 10.1007\/s00787-011-0163-7","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-021-01899-z","article-title":"European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment","volume":"31","author":"Roessner V","year":"2022","unstructured":"Roessner V, Eichele H, Stern JS, et al.. European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment. Eur Child Adolesc Psychiatry. 2022, 31:425-41. 10.1007\/s00787-021-01899-z","journal-title":"Eur Child Adolesc Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/156891-successful-treatment-of-tourette-syndrome-with-a-combination-of-guanfacine-and-aripiprazole-a-case-series","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:03:26Z","timestamp":1707509006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/156891-successful-treatment-of-tourette-syndrome-with-a-combination-of-guanfacine-and-aripiprazole-a-case-series"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,27]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.39573","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,27]]}}}